<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33890344</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov Disord</ISOAbbreviation></Journal><ArticleTitle>Parkinson's Disease and Post-COVID-19 Syndrome: The Parkinson's Long-COVID Spectrum.</ArticleTitle><Pagination><StartPage>1287</StartPage><EndPage>1289</EndPage><MedlinePgn>1287-1289</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.28622</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leta</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-5794-7540</Identifier><AffiliationInfo><Affiliation>King's College London, Department of Neurosciences, Institute of Psychiatry, Psychology &amp; Neuroscience, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Violante</LastName><ForeName>Mayela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6041-9941</Identifier><AffiliationInfo><Affiliation>Clinical Neurodegenerative Research Unit, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Movement Disorder Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abundes</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Neurodegenerative Research Unit, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Movement Disorder Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rukavina</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>King's College London, Department of Neurosciences, Institute of Psychiatry, Psychology &amp; Neuroscience, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teo</LastName><ForeName>James T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>King's College London, Department of Neurosciences, Institute of Psychiatry, Psychology &amp; Neuroscience, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College Hospital National Health Service Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falup-Pecurariu</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Transilvania University of Bra&#x219;ov, Bra&#x219;ov, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, County Emergency Clinic Hospital, Bra&#x219;ov, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irincu</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Faculty of Medicine, Transilvania University of Bra&#x219;ov, Bra&#x219;ov, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, County Emergency Clinic Hospital, Bra&#x219;ov, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rota</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King's College London, Department of Neurosciences, Institute of Psychiatry, Psychology &amp; Neuroscience, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhidayasiri</LastName><ForeName>Roongroj</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6901-2064</Identifier><AffiliationInfo><Affiliation>Chulalongkorn Centre of Excellence for Parkinson's Disease &amp; Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Storch</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases Rostock/Greifswald, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Translational Neurodegeneration Section "Albrecht Kossel," University of Rostock, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odin</LastName><ForeName>Per</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonini</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1040-2807</Identifier><AffiliationInfo><Affiliation>Parkinson and Movement Disorders Unit, Department of Neuroscience, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ray Chaudhuri</LastName><ForeName>Kallol</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2815-0505</Identifier><AffiliationInfo><Affiliation>King's College London, Department of Neurosciences, Institute of Psychiatry, Psychology &amp; Neuroscience, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Parkinson's Foundation Centre of Excellence, King's College Hospital, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Parkinson's disease</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33890344</ArticleId><ArticleId IdType="pmc">PMC8250675</ArticleId><ArticleId IdType="doi">10.1002/mds.28622</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Antonini A, Leta V, Teo J, Chaudhuri KR. Outcome of Parkinson's disease patients affected by COVID&#x2010;19. Mov Disord 2020;35(6):905&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267273</ArticleId><ArticleId IdType="pubmed">32347572</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Schultz JL, Aldridge GM, Simmering JE, Narayanan NS. Coronavirus disease 2019 case fatality and Parkinson's disease. Mov Disord 2020;35(11):1914&#x2013;1915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537245</ArticleId><ArticleId IdType="pubmed">32954522</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulzer D, Antonini A, Leta V, et al. COVID&#x2010;19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside. NPJ Parkinsons Dis 2020;6:18. 10.1038/s41531-020-00123-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-020-00123-0</ArticleId><ArticleId IdType="pmc">PMC7441399</ArticleId><ArticleId IdType="pubmed">32885037</ArticleId></ArticleIdList></Reference><Reference><Citation>Artusi CA, Romagnolo A, Imbalzano G, et al. COVID&#x2010;19 in Parkinson's disease: Report on prevalence and outcome. Parkinsonism Relat Disord 2020;80:7&#x2013;9. 10.1016/j.parkreldis.2020.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2020.09.008</ArticleId><ArticleId IdType="pmc">PMC7474816</ArticleId><ArticleId IdType="pubmed">32920322</ArticleId></ArticleIdList></Reference><Reference><Citation>Cilia R, Bonvegna S, Straccia G, et al. Effects of COVID&#x2010;19 on Parkinson's disease clinical features: a community&#x2010;based case&#x2010;control study. Mov Disord 2020;35(8):1287&#x2013;1292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280741</ArticleId><ArticleId IdType="pubmed">32449528</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health and Care Excellence (NICE)
. COVID&#x2010;19 rapid guideline: managing the long&#x2010;term effects of COVID&#x2010;19. https://www.nice.org.uk/guidance/NG188. Accessed February 1, 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GA, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv 2020. 10.1101/2020.12.24.20248802</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.24.20248802</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>